Sally A. Huber

ORCID: 0009-0009-4441-9667
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Viral Infections and Immunology Research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Cytomegalovirus and herpesvirus research
  • Atherosclerosis and Cardiovascular Diseases
  • interferon and immune responses
  • Cytokine Signaling Pathways and Interactions
  • Monoclonal and Polyclonal Antibodies Research
  • Immunotherapy and Immune Responses
  • Adipokines, Inflammation, and Metabolic Diseases
  • RNA regulation and disease
  • Animal Virus Infections Studies
  • Diabetes and associated disorders
  • Viral gastroenteritis research and epidemiology
  • RNA and protein synthesis mechanisms
  • Cardiovascular Effects of Exercise
  • Herpesvirus Infections and Treatments
  • Cardiomyopathy and Myosin Studies
  • Whipple's Disease and Interleukins
  • CAR-T cell therapy research
  • Infective Endocarditis Diagnosis and Management
  • IL-33, ST2, and ILC Pathways
  • NF-κB Signaling Pathways
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Cardiac Fibrosis and Remodeling

University of Vermont
2015-2025

Munich Leukemia Laboratory (Germany)
2024

University Medical Center Hamburg-Eppendorf
2016-2023

Weatherford College
2023

Universität Hamburg
2016-2023

J.M. Huber Corporation (United States)
2006-2021

Kantonsspital Aarau
2020

Invision Sally Jobe
2012-2018

Thomas Jefferson University
1991-2006

Mayo Clinic
2001

Abstract —Acute-phase proteins, which respond to systemic proinflammatory cytokines such as interleuken-6, are elevated in cardiovascular disease and predictive markers of future ischemic events, even over decades. This suggests a role for and/or acute phase proteins early lesion development. To explore this issue, we fed C57Bl/6 nonobese diabetic male mice high-fat (20% total fat, 1.5% cholesterol) diets ApoE-deficient both normal chow 6 21 weeks, injecting them weekly with either 5000 U...

10.1161/01.atv.19.10.2364 article EN Arteriosclerosis Thrombosis and Vascular Biology 1999-10-01

Coxsackievirus infections have previously been shown to cause acute or chronic myocarditis in humans, and several mouse models established study the pathology of this disease. Myocardial injury may result from direct viral effects and/or be immune mediated. To determine relative roles these processes pathogenesis, we compared coxsackievirus B3 (CVB3) normal immuno-compromised transgenic knockout (ko) mice. CVB3 was able infect all strains used (C57BL/6, CD4ko, beta-microglobulin ko [beta...

10.1128/jvi.69.11.6720-6728.1995 article EN Journal of Virology 1995-11-01

Coxsackievirus B3 (CVB3) infections induce myocarditis in humans and mice. Little is known about the molecular characteristics of CVB3 that activate cellular immunity responsible for cardiac inflammation. Previous experiments have identified an antibody escape mutant (H310A1) a myocarditic variant (H3) attenuates potential virus mice spite ongoing viral replication heart. We cloned full-length infectious cDNA copies genome both wild-type H3 H310A1. Progeny viruses maintained attenuated...

10.1128/jvi.70.11.7811-7818.1996 article EN Journal of Virology 1996-11-01

Male and female BALB/c mice differ dramatically in susceptibility to myocarditis subsequent coxsackievirus B3 (CVB3) infection. CVB3 infection of male results substantial inflammatory cell infiltration the myocardium, virus-immune lymphocytes from these animals give predominantly a Th1 phenotypic response, as determined by predominant immunoglobulin G2a isotypic antibody production elevated numbers gamma interferon interleukin-2 (IL-2)-producing CD4+ T lymphocytes. Females infected with same...

10.1128/jvi.68.8.5126-5132.1994 article EN Journal of Virology 1994-08-01

Background —T cells are implicated in atherosclerosis, but little is known about the genetic control or molecular pathways, especially under conditions of mild hypercholesterolemia. Methods and Results —BALB/c mice, making a CD4+ Th2 (IL-4+) cell response, express both MHC class II antigens (IA d , IE ) atherosclerosis-resistant. C57Bl/6 mice produce Th1 (interferon [IFN]γ+) IA b no IE, atherosclerosis-prone. To evaluate T helper–cell phenotype fatty streak formation, wild-type +IE−)...

10.1161/01.cir.103.21.2610 article EN Circulation 2001-05-29

Understanding the DNA elements that constitute and control regulatory genome is critical for appropriate therapeutic management of complex diseases. Here, using chromosome Y (ChrY) consomic mouse strains on C57BL/6J (B6) background, we show susceptibility to two diverse animal models autoimmune disease, experimental allergic encephalomyelitis (EAE) myocarditis, correlates with natural variation in copy number Sly Rbmy multicopy ChrY genes. On B6 possesses gene properties impact genome-wide...

10.1101/gr.156703.113 article EN cc-by-nc Genome Research 2013-06-25

Abstract Coxsackievirus B3 infections of C57BL/6 mice, which express the MHC class II IA but not IE Ag, results in virus replication heart minimal myocarditis. In contrast, Bl.Tg.Eα are mice transgenically induced to develop significant myocarditis upon infection. Despite this difference inflammatory damage, cardiac titers similar between and mice. Removing γδ T cells from either strain by genetic manipulation (γδ knockout(ko)) changes disease phenotype. ko show increased decreased...

10.4049/jimmunol.165.8.4174 article EN The Journal of Immunology 2000-10-15

Allergic airway inflammation and hyperreactivity are modulated by gammadelta T cells, but different experimental parameters can influence the effects observed. For example, in sensitized C57BL/6 BALB/c mice, transient depletion of all TCR-delta(+) cells just before challenge resulted hyperresponsiveness (AHR), caused hyporesponsiveness when initiated i.p. sensitization. Vgamma4(+) strongly suppressed AHR; their relieved suppression challenge, not sensitization, they AHR transferred into...

10.4049/jimmunol.172.5.2894 article EN The Journal of Immunology 2004-03-01

The Lyme disease spirochete Borrelia burgdorferi is the only known human pathogen that directly activates invariant NKT (iNKT) cells. number and activation kinetics of iNKT cells vary greatly among different strains mice. We now report role cell response in pathogenesis using C57BL/6 mice, a strain with optimal resistant to development spirochetal-induced inflammation. During experimental infection B6 mice B. burgdorferi, localize inflamed heart where they are activated by CD1d-expressing...

10.4049/jimmunol.0804111 article EN The Journal of Immunology 2009-03-06

Both coxsackievirus B3 (CVB3) and influenza A virus (IAV; H1N1) produce sexually dimorphic infections in C57BL/6 mice. Gonadal steroids can modulate sex differences response to both viruses. Here, the effect of chromosomal complement viral infection was evaluated using four core genotypes (FCG) mice, where Sry gene is deleted from Y chromosome, some mice inserted into an autosomal chromosome. This results genotypes: XX or XY gonadal females (XXF XYF), males (XXM XYM). The FCG model permits...

10.1186/2042-6410-2-8 article EN cc-by Biology of Sex Differences 2011-01-01

Background Adaptive immunity has been implicated in atherosclerosis animal models and small clinical studies. Whether chronic immune activation is associated with otherwise healthy individuals remains underexplored. We hypothesized that of adaptive responses, as reflected by higher proportions circulating CD4+ memory cells lower naive cells, would be subclinical atherosclerosis. Methods Findings examined cross-sectional relationships T biomarkers inflammation, serologies, 912 participants...

10.1371/journal.pone.0071498 article EN cc-by PLoS ONE 2013-08-23

T cells expressing the Vgamma4 T-cell receptor (TCR) promote myocarditis in coxsackievirus B3 (CVB3)-infected BALB/c mice. CD1, a major histocompatibility complex (MHC) class I-like molecule, is required for activation of Vgamma4(+) cells. Once activated, initiate through gamma interferon (IFN-gamma)-mediated induction CD4(+) helper type 1 (Th1) infected animal. These Th1 are an autoimmune CD8(+) alphabeta TCR(+) effector, which predominant pathogenic agent this model CVB3-induced...

10.1128/jvi.76.21.10785-10790.2002 article EN Journal of Virology 2002-10-04

Two variants of coxsackievirus B3 (CVB3) which differ dramatically in the ability to induce myocarditis BALB/c mice were studied. H3 virus infection murine monocytes vitro resulted release concentrations interleukin 1 (IL-1) and alpha/beta interferon that high compared with those cells infected H310A1 variant. In vivo, caused substantial inflammatory cell infiltration myocardium, lymphocytes from these animals gave predominantly Th1-cell responses either whole or overlapping peptides CVB3...

10.1128/jvi.68.1.195-206.1994 article EN Journal of Virology 1994-01-01

Immunologic similarities have been demonstrated between Coxsackievirus B3 (CVB3), group A streptococcal M protein, and cardiac myosin. Previous studies also shown that T lymphocytes obtained from CVB3-infected mice expressing the H-2k MHC haplotype gave an immunodominant proliferative response to NT4 peptide (GLKTENEGLKTENEGLKTE) of M5 protein. We now show can induce inflammatory heart disease in MRL/++ (H-2k) induction anergy this protects against CVB3-induced myocarditis. infected with...

10.4049/jimmunol.156.9.3528 article EN The Journal of Immunology 1996-05-01

Innate immunity promotes both the generation of autoimmunity and immunoregulation adaptive immunity. Transgenic mice expressing tumor necrosis factor-α (TNF-α) gene under cardiac myosin promoter (TNF1.6 mice) develop dilated cardiomyopathy. show extensive inflammation, suggesting that immunopathogenic mechanisms may promote Two coxsackievirus B3 (CVB3) variants infect replicate in heart. H3 variant is highly myocarditic, but H310A1 activates CD4 + T regulatory cells, which protect against...

10.1161/01.res.0000249405.13536.49 article EN Circulation Research 2006-10-13
Coming Soon ...